Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease – A phase 1b clinical trial

The Ocular Surface(2025)10.1016/j.jtos.2025.05.009Source: DataRank Database

Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease – A phase 1b clinical trial is a research paper published in The Ocular Surface (2025). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

8 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 5.69)OA: closedTopics (68)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Farshad Abedi ORCID,Arthur Chang ORCID,Xiang Shen ORCID,Mohammad Soleimani ORCID,Iskra Araujo

Live enrichment

PubMed:40414287 OpenAlex:https://openalex.org/W4410698514

U.S. Department of Defense

Grant: W81XWH-14-1-0585

National Institutes of Health

Grant: 4UH3EY031809-02

Phase I Study of Mesenchymal Stromal Cell Secretome for Promoting Corneal Regeneration

National Institutes of Health

Grant: VR170180

NIH HHS

Grant: 4UH3EY031809-0

NEI NIH HHS

Grant: R01 EY017921

Research to Prevent Blindness

National Eye Institute

FWCI

5.69

Citation Percentile

1.0%

Citation Trend

2025

2026

closedLicense: Elsevier TDM

publisherhttps://api.elsevier.com/content/article/PII:S1542012425000709?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1542012425000709?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtos.2025.05.009

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40414287

Fields of Study

Corneal Surgery and TreatmentsOcular Surface and Contact LensMesenchymal stem cell research0303 health sciences03 medical and health sciencesHumansMaleFemaleProspective StudiesMesenchymal Stem Cell TransplantationMiddle AgedConjunctivaCorneal DiseasesAdultEpithelium, CornealInjections, IntraocularAgedMesenchymal Stem CellsVisual AcuityTreatment OutcomeFollow-Up Studies

MeSH Terms

AdultAgedConjunctivaCorneal DiseasesFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesVisual AcuityTreatment OutcomeEpithelium, CornealMesenchymal Stem Cell TransplantationInjections, IntraocularMesenchymal Stem Cells

Keywords

Mesenchymal stem cellMedicineStromal cellDiseaseClinical trialCorneal diseaseCorneaOphthalmologyPathologyRegenerationrepairStem CellsSubconjunctival InjectionMesenchymal Stromal CellPersistent Corneal Epithelial DiseaseMaleAdultEpithelium, CornealVisual AcuityMesenchymal Stem CellsMiddle AgedMesenchymal Stem Cell TransplantationCorneal DiseasesTreatment OutcomeHumansFemaleProspective StudiesInjections, IntraocularConjunctivaAgedFollow-Up Studies

Sustainable Development Goals

SDG 0: Good health and well-being